Nation

DRDO's anti-COVID drug reducing oxygen dependence approved for emergency use

Name: DRDO's anti-COVID drug reducing oxygen dependence approved for emergency use
Uploaded: 2021-05-08T13:45:00Z
Description: The Drugs Controller General of India (DGCI) has granted emergency use approval to an anti-Covid drug 2-deoxy-D-glucose (2-DG) developed by the Defence Research and Development Organisation(DRDO) lab. This after a three-phase clinical trial of the drug had shown a faster recovery of hospitalised patients.

Online Desk

Updated:8th May, 2021 at 7:15 PM

Follow The New Indian Express channel on WhatsApp

Download the TNIE app to stay with us and follow the latest